FDA allows expansion of stem cell trial for ALS

04/18/2013 | Detroit Free Press

The FDA has approved the expansion of a clinical study using human neural stem cells to treat amyotrophic lateral sclerosis. The University of Michigan, Emory University and Neuralstem will take part in the 15-patient midstage trial. Pending approval by an Institutional Review Board, recruitment at Michigan could begin in the summer.

View Full Article in:

Detroit Free Press

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD